Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

940
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
940
Allergic Reactions02:06

Allergic Reactions

27.3K
Overview
27.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

824
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
824
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

719
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
719
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

1.3K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

800
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
800

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Functional profiling of 2,193 ASS1 missense variants: Insights into variant pathogenicity and epistatic interactions in citrullinemia type I.

PLoS genetics·2026
Same author

Predicting epistasis across proteins by structural logic.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Pervasive context-dependent effects in the genetic architecture of complex and quantitative traits revealed by a powerful multiparent mapping population in yeast.

bioRxiv : the preprint server for biology·2025
Same author

A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system.

Disease models & mechanisms·2025
Same author

<i>In vivo</i> validation of the palmitoylation cycle as a therapeutic target in <i>NRAS</i>-mutant cancer.

bioRxiv : the preprint server for biology·2025
Same author

Integrating Training in Opioid Overdose Response in Medical Schools' Curricula: A Systematic Review.

Medical science educator·2025
Same journal

Aripiprazole and Unexpected Salivation: A Case of Drug-Induced Sialorrhea Refractory to Anticholinergics.

Journal of pharmacy practice·2026
Same journal

Exploring Strategies to Educate Reproductive-Aged Individuals About Pharmacist-Prescribed Hormonal Contraception in Indiana: A Qualitative Study.

Journal of pharmacy practice·2026
Same journal

Assessing Kansas Pharmacy Preceptors' Experiences, Knowledge, and Attitudes Toward Pharmacogenomics.

Journal of pharmacy practice·2026
Same journal

The Impact of Academic Detailing on Clinician and Patient Outcomes: A Narrative Review.

Journal of pharmacy practice·2026
Same journal

Management of a Kratom and Tianeptine Overdose.

Journal of pharmacy practice·2026
Same journal

Strategies for Substituting ADHD Medications During Stimulant Shortages.

Journal of pharmacy practice·2026
查看所有相关文章

相关实验视频

Updated: Jun 17, 2025

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.6K

阿米奥达龙诱导的过敏反应

Michelle Tang1, Nitya Nunna1, Qing Zhong1

  • 1Department of Biomedical Sciences, Rocky Vista University College of Osteopathic Medicine, Ivins, UT, USA.

Journal of pharmacy practice
|August 13, 2024
PubMed
概括
此摘要是机器生成的。

阿米奥达龙诱导的过敏反应是罕见但严重的,通常与静脉注射和聚酸盐80有关. 及时治疗对于患者从这种不良药物反应中恢复至关重要.

关键词:
通过IgE介导的过敏反应通过IgG介导的过敏反应巨细胞特异性G蛋白结合受体介导的过敏反应.一个朋友,一个朋友,一个朋友.过敏反应是一种过敏反应.化的含量是多少? 化的含量是多少?聚酸盐 80 80 的情况.

更多相关视频

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K
A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

10.6K

相关实验视频

Last Updated: Jun 17, 2025

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.6K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.6K
A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor
08:22

A Chronic Cardiac Ischemia Model in Swine Using an Ameroid Constrictor

Published on: October 9, 2017

10.6K

科学领域:

  • 心脏病学 心脏病学
  • 过敏和免疫学 过敏和免疫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 阿米奥达龙诱导的过敏反应是一种很少报告的,但可能是严重的不良药物事件.
  • 亚米奥达龙诱导的过敏反应背后的确切机制在很大程度上仍未知.
  • 这项研究调查了报告的病例和潜在的促成因素.

研究的目的:

  • 审查和分析已记录的阿米奥达龙诱导的过敏反应病例.
  • 为了确定amiodarone诱导的过敏反应的潜在触发因素和临床表现.
  • 评估聚酸盐80和在阿米奥达龙诱导的过敏反应中的作用.

主要方法:

  • 通过使用关键词进行文献搜索:"阿米奥达龙"",过敏症"",80多酸盐"和"低血压".
  • 在FDA不良事件报告系统 (FAERS) 数据库中搜索了阿米奥达龙相关的过敏反应病例 (1969-2024).

主要成果:

  • 确定了10个文学案例和89个FAERS报告,这些病例是阿米奥达龙诱导的过敏反应.
  • 静脉注射阿米奥达龙是最常见的触发因素,通常导致严重的低血压.
  • 临床表现包括支气管,皮疹,血管和无意识;在文献病例中,及时治疗导致完全康复,而FAERS报告了14例死亡.

结论:

  • 聚酸盐80,阿米奥达龙本身和化物可能会导致过敏反应.
  • 早期识别和及时的医疗干预对于管理阿米奥达龙诱导的过敏反应至关重要.
  • 需要进一步的研究来阐明具体的机制.